Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy?

Alnylam Pharmaceuticals (ALNY) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

Applied Materials (AMAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Applied Materials (AMAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Applied Materials (AMAT) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

The market expects West Pharmaceutical Services (WST) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This

Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Waters (WAT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on lower revenues when Agios Pharmaceuticals (AGIO) reports results for the quarter ended December 2025. While this widely-known consensus

Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?
Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Zoetis (ZTS) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

TransUnion (TRU) Earnings Expected to Grow: Should You Buy?
TransUnion (TRU) Earnings Expected to Grow: Should You Buy?

The market expects TransUnion (TRU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Restaurant Brands (QSR) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Restaurant, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/6d1f34ee-79e7-4628-b30f-0a4597808d61.png
Restaurant Brands (QSR) Earnings Expected to Grow: Should You Buy?

The market expects Restaurant Brands (QSR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

10x Genomics (TXG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Ingersoll Rand (IR) Reports Next Week: Wall Street Expects Earnings Growth
Ingersoll Rand (IR) Reports Next Week: Wall Street Expects Earnings Growth

Ingersoll Rand (IR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

PBF Energy (PBF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
PBF Energy (PBF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

The market expects PBF Energy (PBF) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus

PG&E (PCG) Earnings Expected to Grow: Should You Buy?
PG&E (PCG) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when PG&E (PCG) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Hyatt Hotels (H) Reports Next Week: Wall Street Expects Earnings Growth
Hyatt Hotels (H) Reports Next Week: Wall Street Expects Earnings Growth

Hyatt Hotels (H) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Eversource Energy (ES) Reports Next Week: Wall Street Expects Earnings Growth
Eversource Energy (ES) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Eversource Energy (ES) reports results for the quarter ended December 2025. While this widely-known consensus

Ladder Capital (LADR) Q4 Earnings and Revenues Lag Estimates
Ladder Capital (LADR) Q4 Earnings and Revenues Lag Estimates

Ladder Capital (LADR) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.27 per share a year ago. These

Here's What Key Metrics Tell Us About MasterCraft Boat Holdings, Inc. (MCFT) Q2 Earnings
Here's What Key Metrics Tell Us About MasterCraft Boat Holdings, Inc. (MCFT) Q2 Earnings

MasterCraft Boat Holdings, Inc. (MCFT) reported $71.76 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 13.2%. EPS of $0.29 for the same period

Sirius XM (SIRI) Reports Q4 Earnings: What Key Metrics Have to Say
Sirius XM (SIRI) Reports Q4 Earnings: What Key Metrics Have to Say

Sirius XM (SIRI) reported $2.19 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 0.2%. EPS of $0.84 for the same period compares to $0.83 a year ago.

After Golden Cross, Enterprise Financial Services (EFSC)'s Technical Outlook is Bright
After Golden Cross, Enterprise Financial Services (EFSC)'s Technical Outlook is Bright

From a technical perspective, Enterprise Financial Services Corporation (EFSC) is looking like an interesting pick, as it just reached a key level of support. EFSC's 50-day simple moving average

Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Biofrontera Inc. (BFRI) has been bearish lately and the stock has lost 9.9% over the past week. However, the formation of a hammer chart pattern in its last trading session

Can TSMC (TSM) Climb 25.25% to Reach the Level Wall Street Analysts Expect?
Can TSMC (TSM) Climb 25.25% to Reach the Level Wall Street Analysts Expect?

Shares of TSMC (TSM) have gained 2.2% over the past four weeks to close the last trading session at $325.74, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts Believe Lam Research (LRCX) Could Rally 30.51%: Here's is How to Trade
Wall Street Analysts Believe Lam Research (LRCX) Could Rally 30.51%: Here's is How to Trade

Lam Research (LRCX) closed the last trading session at $209.78, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Callaway Golf and Albany International have been highlighted as Zacks Bull and Bear of the Day
Callaway Golf and Albany International have been highlighted as Zacks Bull and Bear of the Day

For Immediate Release

Chicago, IL – February 5, 2026 – Zacks Equity Research shares Callaway Golf Co. CALY as the Bull of the Day and Albany International Corp. AIN as the Bear of the Day. In

Hershey Q4 Earnings Top Estimates, Organic Sales Rise on Pricing
Hershey Q4 Earnings Top Estimates, Organic Sales Rise on Pricing

The Hershey Company HSY reported fourth-quarter 2025 results, wherein both the top and bottom lines beat the Zacks Consensus Estimate. On a year-over-year basis, the company’s top line increased

Here's Why Spire (SR) is a Strong Momentum Stock
Here's Why Spire (SR) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Here's Why Yum China Holdings (YUMC) is a Strong Momentum Stock
Here's Why Yum China Holdings (YUMC) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research